← Back to Nuqta Atlas
Editorially curated · qa-hmc-cancer-genetics-program
HMC Cancer Genetics Program
Clinical genetics service providing risk assessment, germline testing, counseling, high-risk surveillance, cascade testing, and reproductive guidance for hereditary cancer syndromes.
01 / Project overview
What the record establishes.
- Geographic scope
- National Center for Cancer Care and Research, Qatar
- Project type
- hereditary cancer clinical program and family registry
- Research domain
- cancer genetics, genetic counseling, and cascade testing
- Years
- 2013–
- Lifecycle status
- active
- Status basis
- HMC maintains a current Cancer Genetics Program service; the QPHI return-of-results pilot describes the program's clinical confirmation, surveillance, and family cascade pathway.
- Status evidence date
- 2026-08-15
- Scale
- No cumulative program count published; the linked QPHI BRCA pilot confirmed 10 carriers, enrolled eight in surveillance, and tested 20 relatives.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Hamad Medical Corporation National Center for Cancer Care and Research
- Partner organizations
- Qatar Precision Health Institute
- Organism / population
- Patients and families with suspected hereditary cancer risk
03 / Data and access
What exists and how it can be reached.
Data types
- germline cancer testing
- family pedigrees
- clinical surveillance
- cascade testing
Data access
Clinical referral; aggregate research publications only.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Long-running national hereditary-cancer genetics pathway and family resource.
Editorial note
Clinical program rather than a single research cohort; closely linked to QPHI's return-of-results program.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0